Bio-Matrix Scientific Group Inc. Announces 20 Million Share

New Post Public Reply Private Reply Replies (0) Message Board
solidgold

Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen BioPharma Dividend to Be Paid to Shareholders

Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen BioPharma Dividend to Be Paid to Shareholders

Date : 10/09/2013 @ 3:11PM
Source : Marketwired
Stock : Bio-matrix Scientific Group, Inc. (QB) (BMSN)
Quote : 0.0019  -0.0001 (-5.00%) @ 2:38PM

Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen BioPharma Dividend to Be Paid to Shareholders

Bio-matrix Scientific Group, Inc. (QB) (USOTC:BMSN)
Intraday Stock Chart

Today : Wednesday 9 October 2013

Click Here for more Bio-matrix Scientific Group, Inc. (QB) Charts.
Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen BioPharma  Dividend to Be Paid to Shareholders

Dividend Is Approximately 40%  Payout of Regen's Issued and Outstanding Shares

SAN DIEGO , CA--(Marketwired - Oct 9, 2013) - Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) today announced that its Board of  Directors has authorized a distribution on a pro rata basis as a dividend in kind of 20,000,000 of the common shares of Regen BioPharma Inc. (" Dividend Shares "), a subsidiary of BMSN, to:

(a)  Holders of record of the outstanding common shares of BMSN as of the record date

(b) Holders of record of the shares of any outstanding series of the  preferred shares of BMSN as of the record date .

Bio-Matrix' Chairman & CEO David Koos stated, "The record date is anticipated to be set as soon as possible after the Form S-1  registering the Dividend Shares under the Securities Act of 1933 is declared effective by the United States  Securities and Exchange Commission (SEC). On a pro rata basis, both common and all classes of preferred  shareholders will receive this dividend. The Company expects the  registration statement to be filed within the next few days with the SEC."

There are 51,610,000 currently outstanding in Regen BioPharma Inc., with Bio-Matrix Scientific Group Inc. owning 50,010,000 of these common shares.

About Regen BioPharma: Regen BioPharma, Inc., a subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN), is a biotechnology company focused on identifying undervalued regenerative medicine applications in the  stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II  clinical trials . For more information refer to  the company's website http://www.regenbiopharma.com/

Disclaimer: This  news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and  uncertainties , some of which cannot be predicted or quantified.  Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:

Bio-Matrix Scientific Group, Inc. and
Regen BioPharma Inc.
David R. Koos, PhD
Chairman &  Chief Executive Officer
619-702-1404
www.regenbiopharma.com

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 90

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
2021 Ferrari Portofino Shines Bright at Jake's Motorcars

Updated Category News Views 67

San Diego might be known for its sunny weather, but Jake's Motorcars just cranked the heat with a 2021 Ferrari Portofino that flaunts a special-ordered Mandarin Orange interior. Now, if that doesn't scream "look at me," I don't know what does. For those who aren't just dabbling in Ferraris but are downright obsessed, let's dig into what makes this sports car not just...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 106

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
OLX Rolls Out New AI Tools Amid Trust Issues

Updated Category News Views 58

A Grounded Approach to AI-Driven Market Evolution OLX Group's stepping into some turbulent waters, folks. They've dropped two new AI-assisted tools, Agentic Selling and DealFinder, while users are still trying to wrap their heads around trusting AI. Now, don't get me wrong, there's potential here—but the road ahead isn't paved with gold just yet. AI-Powered Tools Ready...

Continue Reading
Atlantic Blvd Apartments: A Game-Changer for Housing

Updated Category News Views 18

A Bold Move for Attainable Housing Amidst the hustle and bustle of Sterling, Virginia, a new player has hit the scene: Atlantic Blvd Apartments. A property designed solely for attainable housing, this development is a showcase of what can be accomplished when local government and private developers team up with a shared vision. It feels like a breath of fresh air in a...

Continue Reading
Psoriasis Shines Spotlight on Stigma in 2026 Campaign

Updated Category News Views 42

Peeling Back the Layers of Stigma On World Psoriasis Day, we're flipping the script from pity parties to real change. IFPA's 'Look Beyond My Skin' campaign is rallying against the stigma choking young folks with psoriasis. You can't deny the massive size of this issue – over 100 million people wrangle with this condition globally. Yet, as many of these warriors are...

Continue Reading
EQS Group Unveils 'Q': AI-Driven Compliance Revolution

Updated Category News Views 90

Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...

Continue Reading
EzAccounting: Your Q3 IRS Filing Gets a No-Nonsense Tool

Updated Category News Views 63

Taking Tax Deadlines Head-On Tax season's got businesses sweating all over the country, but it doesn't have to be a full-scale panic attack if you've got the right gear. That's where ezAccounting steps in, dishing out a reliable solution to hit those looming IRS Form 941 deadlines without a migraine. By November 2, 2026, companies are looking to dodge the bullet of...

Continue Reading
Huron Consulting Joins S&P SmallCap 600 Lineup Soon

Updated Category News Views 31

Shuffling the Deck: Huron Consulting Steps In Just when you thought the index shuffle was settled, along comes an eleventh-hour change. Huron Consulting Group is being welcomed with open arms into the S&P SmallCap 600, booting Supernus Pharmaceuticals to the side. Mark November 3 on your calendars—final scorecards before the trading bell could surprise us all. The S&P...

Continue Reading
Innodata Faces Investigation After Major Stock Drop

Updated Category News Views 43

Rough Waters for Innodata, Stock Takes a Hit The market can be a brutal place when news hits hard, and that's precisely the situation Innodata Inc. (NASDAQ: INOD) found itself in on October 27, 2026. After a promising rally, the company's shares plummeted by over 20% when news broke of a significant workforce reduction overseas. Unpacking the Numbers Behind the Dive The...

Continue Reading

Top 5 Most Recently Viewed Articles

Woodward's Upcoming Fireside Chat with Goldman Sachs

Updated Category News Views 88

Woodward to Take Part in Fireside Chat Woodward (NASDAQ: WWD) has announced that Chip Blankenship, the Chairman and Chief Executive Officer, along with Bill Lacey, the Chief Financial Officer, will participate in an engaging virtual fireside chat. This event is hosted by Noah Poponak from Goldman Sachs and is scheduled to occur soon. Details of the Event This virtual...

Continue Reading
JPMorgan Reiterates Overweight Rating for Bank of America

Updated Category News Views 115

JPMorgan's Continued Confidence in Bank of America Recently, Bank of America (NYSE:BAC) has received steadfast support from JPMorgan analysts, who have reaffirmed their Overweight rating on the stock, maintaining a price target of $47. This decision comes on the heels of their reported earnings which, while mixed, showcase the bank's resilience and performance across...

Continue Reading
Vestar's Groundbreaking Event for Verrado Marketplace in 2026

Updated Category News Views 342

The Exciting Future of Verrado Marketplace Vestar has recently announced the groundbreaking of Verrado Marketplace, an upcoming 500,000-square-foot shopping, dining, and entertainment venue in the West Valley. This innovative retail destination aims to provide a unique experience for visitors and residents alike, with an impressive array of restaurants and shops planned...

Continue Reading
Important Legal Updates for DoubleVerify Holdings Investors

Updated Category News Views 135

Understanding the Securities Class Action for DoubleVerify Holdings, Inc. As investors in DoubleVerify Holdings, Inc. navigate the complexities of the securities industry, it's crucial to stay informed about significant legal developments impacting their investments. DoubleVerify (NYSE: DV) is currently facing a class action lawsuit, and understanding the implications of...

Continue Reading
Apple Faces Advertising Scrutiny Over AI Feature Claims

Updated Category News Views 232

Apple's Advertising Under Review for AI Feature Claims The National Advertising Division (NAD) of BBB National Programs has recommended that Apple Inc. revise or cease claims regarding the availability of certain features linked to its AI-powered tool known as Apple Intelligence. This recommendation comes as part of NAD's ongoing marketplace monitoring efforts to ensure...

Continue Reading